MetaCap

Profusa (PFSA) vs Vivos Therapeutics (VVOS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Profusa is the larger company by market cap ($1.8 million vs $1.8 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PFSA-78.44%VVOS-64.24%
+4%-39%-82%
Oct 7, 20261 yearNov 20, 2026
PFSA-77.23%VVOS-63.73%
+4%-39%-81%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PFSA versus VVOS key metrics
MetricPFSAVVOS
Share price$0.3234$0.054
Market cap$1.84M$1.83M
1-day change-6.40%-5.10%
P/E ratio (TTM)0.00—
EPS (TTM)$6,415.28$-1.35
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$17.44M
Revenue growth (YoY)—+16.05%
Net income (latest FY)$-35.82M$-21.17M
Gross margin—60.44%
Operating margin—-114.05%
Net margin—-121.37%
52-week high$1,515.00$2.69
52-week low$0.31$0.05
Distance from 52-week high-99.98%-97.99%
Analyst consensus—none
Avg. price target upside—+3825.93%
Average volume2.74M14.44M
Shares outstanding5.68M33.82M
Employees—268
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Profusa

PFSA stock →

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.

Health Care · Medical/Dental Instruments

About Vivos Therapeutics

VVOS stock →

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.

Health Care · Medical/Dental Instruments · 268 employees

PFSA vs VVOS FAQ

Which is bigger, Profusa or Vivos Therapeutics?

Profusa (PFSA) is larger, with a market capitalization of $1.84M compared with $1.83M for Vivos Therapeutics (VVOS).

Are Profusa and Vivos Therapeutics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons